Sjs Investment Consulting Inc. Ptc Therapeutics, Inc. Transaction History
Sjs Investment Consulting Inc.
- $540 Million
- Q4 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 13 shares of PTCT stock, worth $650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 11
18.18%
Holding current value
$650
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PTCT
# of Institutions
257Shares Held
77.3MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$459 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$389 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$370 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$319 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$239 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.58B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...